What is the Windlas Biotech Limited price band and lot size?

Windlas Biotech Limited is priced at ₹448 – ₹460 per share with a lot size of 30 shares, so the minimum application is ₹13,800.

How much was Windlas Biotech Limited subscribed?

Windlas Biotech Limited was subscribed 22× in total across both exchanges.

How have IPOs like Windlas Biotech Limited performed?

Of the 54 mainboard issues that listed in 2021 and that MarketPing can price, the median return since issue price is +27.5% and 42.6% trade below their issue price. This is a base rate for the cohort, not a forecast for this issue.

ListedMainboardWINDLAS

Windlas Biotech Limited

Windlas Biotech Limited is a mainboard IPO raising ₹165 Cr at ₹448 – ₹460 a share. It listed on 16 Aug 2021 and trades at ₹878 today, +90.9% against its issue price of ₹460. It was subscribed 22× in total.

Get alerts on this company Company page

₹460

Issue price

₹878

Price now

+90.9%

Since issue price

16 Aug 2021

Listed on

22×Subscribed (final) · all exchanges

22.5 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

54 mainboard issues listed in 2021 that we can price today. This is the group this issue belongs to.

+27.5%

Median return since issue price

42.6%

Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB24×

Non-institutional16×

Retail24×

Demand is spread fairly evenly across investor categories.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits

How demand built over timeFinal figure held, but no series — we were not sampling this issue while it was live

Price-point demand curveLive only — NSE stops serving this once bidding closes

Lead managers and registrar3 banks

Official documents4 documents

Listing-day priceNot published for this issue — the exchanges only began carrying it during 2024

Performance since listingComputed from our own daily closes

Led by SBI Capital Markets Limited — median +10.1% across the 57 of its issues we can price. All lead managers →

What happens when

4 AugBidding opens

6 AugBidding closes

11 AugAllotment

12 AugRefunds

16 AugListing

Track WINDLAS BIOTECH LIMITED

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.